Outsourcing Outlook

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-01-01-2003, Volume 27, Issue 1

Developments in 2002 such as acquisitions, excess manufacturing capacity, and less funding for biotechnology will continue to affect the industry long into the new year.

Related Content:

OutsourcingOutsourcing OutlookPharmaceutical Technology-01-01-2003
How New Regulations Are Impacting Pharmaceutical Manufacturing Facility Design
Annex 1 Alignment: Addressing Contamination Control and Assessing Risk
Lonza Forms Agreement to Manufacture Acumen Pharmaceuticals’ AD mAb Therapy